Diagnostic equipment · Pharmaceutical and life sciences
Placement-level return for diagnostic equipment, instrument and reagent together
A diagnostic equipment company often earns little on the analyser and most of its margin on the reagents that run on it for years afterwards. We measure each placement as a single investment. You can then see which laboratories repay the instrument and which never will.
In one paragraph
In-vitro diagnostic and laboratory equipment companies — manufacturers, importers and distributors of analysers, reagents and consumables — usually turn over ₹20–400 crore. They sell to hospitals, laboratories and government buyers, and much of the business runs on reagent rental. An instrument is placed at a customer's site against a commitment to buy reagents. The capital sits on your balance sheet while the revenue arrives test by test. Managing directors and CFOs, often with the head of service, carry both sides.
Managing director or CFO, often with the head of service
The economics
How the money moves in this trade
Under a reagent-rental or placement arrangement, the company installs an analyser at a laboratory, retains ownership and services it. It recovers the cost through reagent pricing over the contract term. The return depends on the volume of tests the laboratory actually runs, which may be well below the volume projected at placement. Outright sales, rentals and placements often coexist, each with different accounting and cash patterns.
Government and institutional business is usually won through tenders. These carry performance guarantees, installation and acceptance conditions, and payment cycles far longer than private customers. An installed base also generates service obligations, spare parts and annual maintenance contracts. Reagent margin, instrument depreciation, service cost and tender receivables all bear on whether a customer is worth having, yet they are reported in different places.
The problem
Where the numbers usually break down
Placements are not tracked as investments
Instruments at customer sites are held as fixed assets in total. Nobody compares each instrument's cost and service burden with the reagent margin from the site it serves.
Committed reagent volumes are not monitored
Placement agreements specify minimum reagent offtake, but shortfalls are rarely measured, and the contractual remedy is seldom enforced.
Tender receivables are aged as a single balance
Amounts held under acceptance, retention and performance guarantee are mixed with ordinary dues, so the real collection position on government business is unclear.
Instruments in the field are not verified
Analysers move between sites, are withdrawn or lie idle, and the fixed-asset register falls out of step with where instruments physically are.
Reagent expiry is absorbed at year end
Short-dated reagents and controls expire in warehouses and at distributors, and the loss is written off in bulk rather than traced to the product or forecast that caused it.
What we do
The work, and the result each part produces
Placement return analysis
Each placed instrument's cost, depreciation and service cost set against the reagent margin from its site over the contract term.
Loss-making placements are identified, and new ones are priced on evidence.
Reagent commitment tracking
Actual reagent offtake compared with contracted minimums for every placement, with shortfalls reported monthly.
Under-performing sites are raised with the customer while the contract can still be enforced.
Tender and institutional receivables
Dues split into billed, under acceptance, retention and guarantee-linked amounts, aged by tender and buyer.
Government business shows its true cash cycle.
Field asset verification
Instruments at customer sites reconciled to the asset register by serial number, with idle and withdrawn units flagged.
The asset register describes where your instruments actually are.
Service and maintenance contract accounting
Maintenance contracts recognised over the period of cover, with engineer time and spare parts charged against each contract.
Service is reported as a business line with its own margin.
Reagent inventory and expiry
Reagent and control stock aged by lot and expiry across warehouses and distributors, with exposure provided for in advance.
Expiry losses are expected, measured and traced to their cause.
Where we start
The first steps of an engagement
Placement contracts and asset register
We ask for the placement and reagent-rental agreements, the fixed-asset register by serial number, reagent sales by customer site, service records and the tender receivables ledger.
Return on the largest placements
For the highest-value placements we set instrument cost, depreciation and service cost against reagent margin from the same site. Actual reagent offtake is compared with the contracted minimum.
Field instruments verified by serial
Instruments at customer sites are reconciled to the asset register by serial number. Idle and withdrawn units are flagged, and moves between sites are recorded when they happen.
Placement return report
The first report ranks placements by return and lists sites below their reagent commitment. It also splits tender dues into billed, under acceptance, retention and guarantee-linked amounts.
How it is measured
The reports the work is judged on
Each is recorded as a baseline before the work starts, so later reports have an honest comparison.
- Return by placement, instrument cost against reagent margin
- Reagent offtake against contracted minimums
- Tender receivables by stage and age
- Field instruments verified to the asset register
- Service contract margin by instrument family
- Reagent stock by expiry band
Who it suits
Written for, and not the right fit for
- You need product registration, import licensing or performance evaluation; those sit with your regulatory team and the authority.
- You need the statutory audit or tax-audit report itself — that is signed by an independently engaged CA, though we prepare the placement and asset schedules it relies on.
- IVD companies running reagent-rental or placement models with hospitals and laboratories.
- Distributors of laboratory analysers carrying both private and government business.
- Equipment companies whose installed base has grown faster than the records that track it.
Services
Services this work draws on
Costing and profitability
What each product, line and customer really contributes.
Explore service ↗MIS and financial planning
Reporting built around the questions you actually need answered.
Explore service ↗Internal controls and risk
Controls sized to your business, documented and actually tested.
Explore service ↗Outsourced accounting
Your books kept current and reconciled, closed to a published calendar.
Explore service ↗Every other service, also available in this trade
Common questions
Questions owners in this trade ask
How do we account for an analyser placed under a reagent contract?
It depends on the contract terms, and some arrangements may contain a lease that needs to be identified. We set out the facts of each contract type and a consistent treatment, which your statutory auditor reviews independently.
Should we stop placing instruments at low-volume sites?
Not necessarily. The placement analysis shows which sites are below break-even and by how much. Sometimes a price or minimum-volume change fixes it; sometimes a smaller instrument does. The commercial call stays with you.
What financial documents does a diagnostics tender ask for?
Usually financial statements, turnover data and working-capital information. We prepare that pack. Technical bids and product compliance documents stay with your team.
5th Quadrant performs costing, asset and inventory reconciliation, contract tracking and reporting work. Diagnostic product registration, import licensing and quality matters are the responsibility of the company and the relevant authority. Statutory audit and prescribed certification are performed by independently engaged licensed professionals. Full detail is on our Professional Scope page.
Explore further